AZOVAS T 80 10S

About

Azovas T 80 is a powerful combination medication formulated to address two critical cardiovascular risk factors: dyslipidemia and hypertension. It comprises Atorvastatin, a highly effective HMG-CoA reductase inhibitor, and Telmisartan, a long-acting angiotensin II receptor blocker. This dual-action therapy is indicated for patients who require both significant lipid-lowering and sustained blood pressure control, especially those with co-existing hypertension and elevated cholesterol levels, or individuals at high risk for major cardiovascular events. Atorvastatin works to reduce elevated levels of LDL-C, total cholesterol, and triglycerides, while Telmisartan provides robust and prolonged blood pressure reduction by selectively blocking the effects of angiotensin II. By targeting these distinct yet interconnected pathways, Azovas T 80 offers comprehensive cardiovascular protection, aiming to reduce the incidence of adverse events such as myocardial infarction and stroke.

Uses

• Treatment of essential hypertension.
• Management of dyslipidemia (high cholesterol).
• Reduction of cardiovascular risk in high-risk patients.
• Prevention of stroke and myocardial infarction.

Directions For Use

Take this medication orally, usually once daily, with or without food, as directed by your physician.

Benefits

• Dual action for blood pressure and cholesterol control.
• Reduces major cardiovascular event risk.
• Effective in patients with co-existing hypertension and dyslipidemia.
• Provides sustained blood pressure reduction.
• Significant reduction in LDL-C levels.
• Convenient once-daily dosing.

Side Effects

• Headache
• Dizziness
• Muscle pain (myalgia)
• Fatigue
• Nausea
• Diarrhea
• Abdominal pain
• Elevated liver enzymes
• Cough
• Hypotension
• Angioedema (rare)
• Rhabdomyolysis (rare)

Safety Measures

• Alcohol - Excessive alcohol consumption should be avoided, especially with atorvastatin, due to increased risk of liver damage. Alcohol can also enhance hypotensive effects.
• Pregnancy - This combination is contraindicated in pregnancy due to potential fetal harm from telmisartan and atorvastatin.
• Breastfeeding - Both telmisartan and atorvastatin are contraindicated during breastfeeding due to potential adverse effects on the infant.
• Liver - Contraindicated in active liver disease or unexplained persistent elevations of serum transaminases. Use with caution in patients with a history of liver disease.
• Kidney - Use with caution in patients with severe renal impairment. Close monitoring of renal function is recommended, especially with telmisartan.
• Lung - Telmisartan may rarely cause a persistent dry cough, which is generally benign. No specific contraindications for lung conditions otherwise.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.